Search research articles
Contact Us
Filters
Showing results (81-90 of 219) with videos related to
Page
of 22
Sort By:
Plos One
|
August 1, 2012
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes
Melissa N Barber, Steve Risis, Christine Yang, et al.
Endocrinology
|
November 26, 2010
Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation
Andrew J Hoy, Clinton R Bruce, Sarah M Turpin, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
January 30, 2004
Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle
Matthew J Watt, Anna G Holmes, Gregory R Steinberg, et al.
International Journal of Sport Nutrition and Exercise Metabolism
|
May 1, 2004
Effect of active versus passive recovery on metabolism and performance during subsequent exercise
Andrew J McAinch, Mark A Febbraio, Joann M Parkin, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 23, 2008
Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise
Shinji Miura, Yuko Kai, Yasutomi Kamei, et al.
Endocrinology
|
November 12, 2010
Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine
Jakob Hansen, Claus Brandt, Anders R Nielsen, et al.
The Journal of Physiology
|
May 17, 2002
Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation
Adam Steensberg, Gerrit van Hall, Charlotte Keller, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
July 15, 2003
Hepatosplanchnic clearance of interleukin-6 in humans during exercise
Mark A Febbraio, Peter Ott, Henning Bay Nielsen, et al.
Plos One
|
June 16, 2012
Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease
Graeme I Lancaster, Greg M Kowalski, Emma Estevez, et al.
Physiological Reports
|
July 5, 2025
The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice
Casey L Egan, Atanaska Doncheva, Martin Pal, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 219) with videos related to
Sort By:
Page
of 22
Plos One
|
August 1, 2012
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes
Melissa N Barber, Steve Risis, Christine Yang, et al.
Endocrinology
|
November 26, 2010
Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation
Andrew J Hoy, Clinton R Bruce, Sarah M Turpin, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
January 30, 2004
Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle
Matthew J Watt, Anna G Holmes, Gregory R Steinberg, et al.
International Journal of Sport Nutrition and Exercise Metabolism
|
May 1, 2004
Effect of active versus passive recovery on metabolism and performance during subsequent exercise
Andrew J McAinch, Mark A Febbraio, Joann M Parkin, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 23, 2008
Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise
Shinji Miura, Yuko Kai, Yasutomi Kamei, et al.
Endocrinology
|
November 12, 2010
Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine
Jakob Hansen, Claus Brandt, Anders R Nielsen, et al.
The Journal of Physiology
|
May 17, 2002
Muscle glycogen content and glucose uptake during exercise in humans: influence of prior exercise and dietary manipulation
Adam Steensberg, Gerrit van Hall, Charlotte Keller, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
July 15, 2003
Hepatosplanchnic clearance of interleukin-6 in humans during exercise
Mark A Febbraio, Peter Ott, Henning Bay Nielsen, et al.
Plos One
|
June 16, 2012
Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease
Graeme I Lancaster, Greg M Kowalski, Emma Estevez, et al.
Physiological Reports
|
July 5, 2025
The proteoglycan decorin does not influence adiposity, glucose tolerance, or aerobic exercise capacity in mice
Casey L Egan, Atanaska Doncheva, Martin Pal, et al.
Page
of 22